Court Consolidates Takeda Antitrust Suits Over IBS Drug
A Massachusetts federal judge on Monday consolidated a pair of proposed class actions alleging that Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal to keep a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article